EP0530861A2
Expired / Lapsed
EP
⏱️ 0.0 years remaining
Topical antimicrobial pharmaceutical compositions
Assignee: Individual
•
Filing: 1987-04-21
•
Granted: —
•
Expires: 2007-04-21
Abstract
Abstract A topical antimicrobial pharmaceutical composition comprising a tertiary mixture comprising: (a) a glyceryl fatty acid ester; (b) a mixture of fatty acids comprising: (i) a first fatty acid antimicrobial agent which is a C₆-C₁₈ fatty acid; and (ii) a second fatty acid antimicrobial agent which is a C₆-C₁₈ fatty acid; and (c) a pharmaceutically acceptable carrier.
Inventors
- 👤 Jon Joseph Kabara
Bibliographic Details
Application Number
—
Jurisdiction
EP
Data Source
google_patents
Last Synchronized
2026-10-23 04:53
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/21; A61K31/215; A61K31/22; A61K31/23; A01; A01N; A01N37/00; A01N37/12; A61K31/185; A61K31/19; A61K31/20; A61K31/25; A61P; A61P17/00; A61P31/00; A61P31/04; A61P31/12
Claims Analysis
Total Claims: 12
Claim 1
Independent Claim
56 words
A topical antimicrobial pharmaceutical composition comprising a tertiary mixture comprising: (a) a glyceryl fatty acid ester; (b) a mixture of fatty acids comprising: (i) a first fatty acid antimicrobial agent which is a C₆-C₁₈ fatty acid; and (ii) a second fatty acid antimicrobial agent which is a C₆-C₁₈ fatty acid; and (c) a pharmaceutically acceptable carrier.
Claim 2
Dependent Claim
29 words
A topical antimicrobial pharmaceutical composition according to claim 1 wherein the ratio by weight of the ester to the first and second fatty acids combined is 1:10 to 10:1.
Claim 3
Dependent Claim
34 words
A topical antimicrobial pharmaceutical composition according to claim 1 or 2 wherein the first fatty acid and/or the second fatty acid is a straight chain fatty acid having from six to twelve carbon atoms.
Claim 4
Dependent Claim
23 words
A topical antimicrobial pharmaceutical composition according to any one of claims 1 to 3 wherein the glyceryl fatty acid ester is a monoester.
Claim 5
Dependent Claim
18 words
A topical antimicrobial pharmaceutical composition according to claim 4 wherein the monoester contains 6 to 21 carbon atoms.
Claim 6
Dependent Claim
25 words
A topical antimicrobial pharmaceutical composition according to claim 5 wherein the monoester is monocaprylin, monocaprin, monolaurin, monomyristin, monopalmitolein, monolein, monoicosenoin, monoerucin or a mixture thereof.
Claim 7
Dependent Claim
31 words
A topical antimicrobial pharmaceutical composition according to any one of claims 4 to 6 wherein the monoester is present in an amount of 0.025 to 20.0% by weight of the composition.
Claim 8
Dependent Claim
30 words
A topical antimicrobial pharmaceutical composition according to any one of claims 1 to 7 in which the carrier comprises an alcohol, chelating agent, surfactant, paraben, water, or a mixture thereof.
Claim 9
Dependent Claim
77 words
A topical antimicrobial pharmaceutical composition according to claim 8 wherein the pharmaceutical carrier comprises an alcohol which is propylene glycol, phenoxyethanol, methanol, ethanol, isopropyl alcohol, or a mixture thereof; a chelating agent which is EDTA, Na₂(EDTA), Na₄(EDTA), TEA, lactic acid, critric acid or a mixture thereof; a surfactant which is a sarcosinate, an amine oxide, pluronic 68, sodium lauryl sulfate or a mixture thereof; or a paraben which is methyl paraben, propyl paraben or a mixture thereof.
Claim 10
Dependent Claim
46 words
A topical antimicrobial pharmaceutical composition according to claim 8 or 9 which comprises 5% to 60% by volume of the alcohol; 0.25% to 10% by weight of the surfactant; 0.05% to 5% by weight of the parabens; 0.05% to 4% by weight of the chelating agent.
Claim 11
Dependent Claim
18 words
A composition according to any one of claims 1 to 10 for use as a topical antimicrobial agent.
Claim 12
Dependent Claim
21 words
Use of a composition according to any one of claims 1 to 11 in the preparation of a topical antimicrobial medicament.
References Cited (Backward Citations)
No citation records indexed.
USPTO Annuity & Maintenance Windows
Maintenance schedule is calculated for granted US utility patents.